Article Versions Notes

Ammendola S, Romeo S, Cattazzo F, Mantovani A, Ieluzzi D, Paon V, Montagnana M, Pecori S, Tomezzoli A, Dalbeni A, et al. Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies—A Case-Control Study. International Journal of Molecular Sciences. 2024; 25(2):784. https://doi.org/10.3390/ijms25020784

Ammendola, Serena, Sara Romeo, Filippo Cattazzo, Anna Mantovani, Donatella Ieluzzi, Veronica Paon, Martina Montagnana, Sara Pecori, Anna Tomezzoli, Andrea Dalbeni, and et al. 2024. "Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies—A Case-Control Study" International Journal of Molecular Sciences 25, no. 2: 784. https://doi.org/10.3390/ijms25020784

Ammendola, S., Romeo, S., Cattazzo, F., Mantovani, A., Ieluzzi, D., Paon, V., Montagnana, M., Pecori, S., Tomezzoli, A., Dalbeni, A., & Sacerdoti, D. (2024). Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies—A Case-Control Study. International Journal of Molecular Sciences, 25(2), 784. https://doi.org/10.3390/ijms25020784